ASH 2019

References for The Total Direct Cost of Healthcare in the United States in Patients with Sickle Cell Disease: A Propensity Score Matched Analysis by Jonathan Salcedo, MA, Colin Young, PhD, and Jenniffer Bulovic, MD, MPH

1.	Amendah DD, Mvundura M, Kavanagh PL, Sprinz PG, Grosse SD. Sickle cell disease-related pediatric medical expenditures in the U.S. Am J Prev Med. 2010;38(4 Suppl):S550-556.
2.	Kauf TL, Coates TD, Huazhi L, Mody-Patel N, Hartzema AG. The cost of health care for children and adults with sickle cell disease. Am J Hematol. 2009;84(6):323-327.
3.	Carroll CP, Haywood C, Jr., Fagan P, Lanzkron S. The course and correlates of high hospital utilization in sickle cell disease: Evidence from a large, urban Medicaid managed care organization. Am J Hematol. 2009;84(10):666-670.
4.	Blinder MA, Duh MS, Sasane M, Trahey A, Paley C, Vekeman F. Age-Related Emergency Department Reliance in Patients with Sickle Cell Disease. J Emerg Med. 2015;49(4):513-522.e511.
5.	Blinder MA, Vekeman F, Sasane M, Trahey A, Paley C, Duh MS. Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs. Pediatr Blood Cancer. 2013;60(5):828-835.
6.	Optum.com. Optum research data assets.  https://www.optum.com/content/dam/optum/resources/productSheets/5302_Data_Assets_Chart_Sheet_ISPOR.pdf. Accessed August 4, 2019.
7.	Solovieff N, Hartley SW, Baldwin CT, et al. Ancestry of African Americans with sickle cell disease. Blood Cells Mol Dis. 2011;47(1):41-45.
8.	Michalik DE, Taylor BW, Panepinto JA. Identification and Validation of a Sickle Cell Disease Cohort Within Electronic Health Records. Acad Pediatr. 2017;17(3):283-287.
9.	Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41-55.
10.	Austin PC. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate Behav Res. 2011;46(3):399-424.
11.	Austin PC. Goodness-of-fit diagnostics for the propensity score model when estimating treatment effects using covariate adjustment with the propensity score. Pharmacoepidemiol Drug Saf. 2008;17(12):1202-1217.